Darker Skin Phototypes Research Articles

Latin American consensus on the treatment of melasma.

Melasma is a chronic, relapsing hyperpigmentation disorder that primarily affects photoexposed areas, occurring most frequently in adult women with darker skin phototypes. The primary factors contributing to its development include sun exposure, sex hormones (e.g., pregnancy), and genetic predisposition. Melasma is highly prevalent in Latin America, where many countries lie in intertropical zones and exhibit significant ethnic diversity because of centuries of intermixing among Native Americans, Europeans, and Sub-Saharan Africans. Nine Latin American experts formulated a DELPHI-based consensus to develop a valuable approach for treating melasma in this diverse population. After establishing an accurate diagnosis, assessing the impact on quality of life, and determining disease severity, the consensus recommends mitigating known triggers and promoting rigorous photoprotection. Active therapy should be tailored based on individual characteristics (e.g., pregnancy status, previous treatments, skin sensitivity). Treatment options include topical depigmenting agents, systemic therapies, and procedural interventions such as laser therapy, microneedling, and chemical peels. Periodic reassessment of the treatment is essential, with strategies adjusted if targeted outcomes are not achieved. Once clinical remission is attained, patients should continue using topical depigmenting agents and maintain strict photoprotection measures to prevent recurrence.

AI in Psoriatic Disease: Scoping Review.

Artificial intelligence (AI) has many applications in numerous medical fields, including dermatology. Although the majority of AI studies in dermatology focus on skin cancer, there is growing interest in the applicability of AI models in inflammatory diseases, such as psoriasis. Psoriatic disease is a chronic, inflammatory, immune-mediated systemic condition with multiple comorbidities and a significant impact on patients' quality of life. Advanced treatments, including biologics and small molecules, have transformed the management of psoriatic disease. Nevertheless, there are still considerable unmet needs. Globally, delays in the diagnosis of the disease and its severity are common due to poor access to health care systems. Moreover, despite the abundance of treatments, we are unable to predict which is the right medication for the right patient, especially in resource-limited settings. AI could be an additional tool to address those needs. In this way, we can improve rates of diagnosis, accurately assess severity, and predict outcomes of treatment. This study aims to provide an up-to-date literature review on the use of AI in psoriatic disease, including diagnostics and clinical management as well as addressing the limitations in applicability. We searched the databases MEDLINE, PubMed, and Embase using the keywords "AI AND psoriasis OR psoriatic arthritis OR psoriatic disease," "machine learning AND psoriasis OR psoriatic arthritis OR psoriatic disease," and "prognostic model AND psoriasis OR psoriatic arthritis OR psoriatic disease" until June 1, 2023. Reference lists of relevant papers were also cross-examined for other papers not detected in the initial search. Our literature search yielded 38 relevant papers. AI has been identified as a key component in digital health technologies. Within this field, there is the potential to apply specific techniques such as machine learning and deep learning to address several aspects of managing psoriatic disease. This includes diagnosis, particularly useful for remote teledermatology via photographs taken by patients as well as monitoring and estimating severity. Similarly, AI can be used to synthesize the vast data sets already in place through patient registries which can help identify appropriate biologic treatments for future cohorts and those individuals most likely to develop complications. There are multiple advantageous uses for AI and digital health technologies in psoriatic disease. With wider implementation of AI, we need to be mindful of potential limitations, such as validation and standardization or generalizability of results in specific populations, such as patients with darker skin phototypes.

The Safe and Effective Profile of Using the 1340 nm Wavelength in Conjunction with Other Therapeutic Modalities for Skin Rejuvenation. A Case Series.

Objective: This study provided clinical findings supporting the use of combination techniques/products and Nd:YAP 1340 nm fractional laser therapy, for soft-tissue augmentation in light- and darker-skin phototypes. Background: The face's aging process is complex and involves skin alterations, connective tissues, bone, and fat layers of the face. Methods: A total of 17 female patients were treated for wrinkles and for scars with the use of Nd:YAP 1340 nm fractional laser combined with other cosmetic therapies. The mean of 4.6(±1.9) laser treatment sessions every 1 month were performed. The combined therapy was administered every 3 months during the total course of the laser treatments. Results: The total mean improvement was 3.64(±0.49). Clinical images showed a visible aesthetic improvement. No adverse events have been reported. Conclusion: The combination therapies used have shown promise in maintaining safety and tolerability while improving patient results for the management of skin aging.

Efficacy, safety, tolerability and treatment durability of microneedling plus topical tranexamic acid in combination with topical modified Kligman lightening formula for melasma: A four-arm assessor and analyst blinded randomized controlled clinical trial.

The challenging management of melasma highlights the inadequacies of conventional therapies and their high risk of recurrence. Integrating microneedling for device-assisted drug delivery with tranexamic acid (TA), recognized for its melanin synthesis inhibition, presents a novel approach that warrants further investigation to fully assess its potential in enhancing melasma treatment efficacy. Fifty moderate to severe melasma patients participated in this randomized outcome-assessor-blinded controlled trial. Patients were randomly allocated into two main groups. Group A received a modified Kligman formula on one hemi-face on alternate nights for 2 months (A1) and three sessions of microneedling with 10% topical TA on the other hemi-face at 1-month intervals (A2). Group B used the same modified Kligman formula on both sides of the face, with one side additionally receiving three sessions of microneedling with 4% TA (B1) and the opposite side with 10% TA (B2). Primary outcomes were % Modified Melasma Area and Severity Index (mMASI) and % visual analogue scale (VAS) change during 6 month follow-up. Adverse events including post-inflammatory hyperpigmentation (PIH) and treatment tolerability were recorded. Compared to baseline, the mean mMASI reduction immediately after the final session was higher in A1, B1, and B2 (56.84%, 50.88%, and 55.87%, respectively) than in A2, which saw only a 13.16% reduction. Efficacy notably declined after the cessation of treatment across all groups. While the efficacy within groups A1, B1, and B2 was comparable, microneedling with 4% or 10% TA combined with the topical modified Kligman formula proved more potent in patients at a lower risk of PIH. Overall, 22% of patients reported PIH, particularly in the A2 group (28% of hemi-faces), with its occurrence significantly associated with treatment during warmer seasons and in darker skin phototypes. Other adverse events were not observed in any patient. Patient satisfaction was highest in groups B1 and B2, where approximately 72% reported 'excellent' satisfaction. The lowest durability rate (16%) was observed in group A2, while the highest (72%) was seen in group B2, comparable with groups A1 and B1. Treatment tolerability was reported 100% in all groups. It was found that the modified Kligman formula outperformed microneedling-TA alone. However, with optimal patient selection, particularly targeting those at lower risk for PIH with lighter skin phototypes and scheduling treatments during less-sunny seasons, combining microneedling with 4% or 10% TA and the modified Kligman formula significantly enhanced efficacy and satisfaction rates compared to conventional topical treatment.

Dermoscopy aids in differentiating café-au-lait macules from congenital melanocytic nevi in patients with darker skin phototypes.

Dermoscopy aids in the diagnosis and management of pigmented growths and disorders of pigmentation in children. However, there is limited literature on the dermoscopic appearance of café-au-lait macules (CALMs) and congenital melanocytic nevi in patients with dark skin. We report two cases of young children with dark skin and many hyperpigmented patches in whom dermoscopy was utilized to accurately diagnose CALMs and facilitate testing for neurofibromatosis.

Niveles de vitamina D en un área de baja radiación solar del norte de la península ibérica

Introduction: vitamin D deficiency is a cause of concern in Europe, especially in latitudes above the 40° N parallel, and several clinical factors are involved. Most prevalence studies in the paediatric population in Spain have been carried out in latitudes with high sunlight exposure. Materials and Methods: cross-sectional descriptive study in two periods (summer and winter seasons) in healthy children aged 2 to 14 years between July 15, 2013 and April 15, 2016, through data collection and blood analysis (calcifediol, calcium, phosphorus) in a total of 603 children residing in La Garrotxa (Girona) (latitude 42° N), an area in Catalonia with low sun exposure. We calculated prevalences and performed a multivariable regression analysis to determine the impact of different clinical variables. Results: 31.86% of children had levels of vitamin D below 20 ng/mL that increased to 52.87% in winter. Ethnicity, phototype and season of the year accounted for 53.2% of the observed variation. Conclusions: children in an area of low solar radiation of Spain had a high prevalence of hypovitaminosis D, especially in the winter, in those with dark skin phototypes and in certain ethnic groups.

Review of Fractional Nonablative Lasers for the Treatment of Dermatologic Conditions in Darker Skin Phototypes.

Fractional nonablative lasers (NAFLs) have demonstrated efficacy and safety for treating dermatologic conditions in patients with darker skin phototypes. Nonablative lasers are preferred in darker skin tones due to lower risk of postinflammatory hyperpigmentation. This review aims to identify the ideal laser options and parameters for treating common dermatologic conditions in patients with skin types IV-VI. A comprehensive literature search was conducted on PubMed in May 2023. Of 1,065 articles were identified, and 40 articles met the inclusion criteria. The studies were classified based on design, dermatologic condition, and skin phototype of patients, and assigned levels of evidence according to the Modified Criteria of the Oxford Center of Evidence Based Medicine. Strong level 1 evidence supports the treatment of melasma and atrophic scars using NAFL. Moderate level 2 evidence was found for using NAFL in acne vulgaris, striae, and skin rejuvenation; 45% of the studies examined skin types III-IV, 20% III-V, 7.5% II-IV, 5% II-V, 5% IV alone, and 2.5% I-IV. Further research is needed to determine the optimal treatment modalities and parameters for skin types V and VI. Appropriate device selection and conservative treatment settings are crucial for optimizing outcomes and minimizing adverse events.

Stigma in Vitiligo: associated factors and severity strata of the PUSH-D score.

Vitiligo is the most common cause of skin depigmentation worldwide. Patients with vitiligo may experience stigma and this needs to be addressed. To evaluate stigma in patients with vitiligo, search for associated factors and establish severity strata for PUSH-D for patients with vitiligo. We conducted a cross-sectional study in ComPaRe vitiligo, an e-cohort of adult vitiligo patients. Stigmatization was assessed using the PUSH-D, a recently validated dermatology-specific stigmatization assessment tool. We conducted univariate and multivariable linear regression to identify patient and disease factors associated with the stigmatization. We used an anchor-based approach to define severity strata of the PUSH-D score. In total, 318 patients participated in this study. The mean age was 49.7 years and 73.9 % of the patients were women. Dark Skin phototype (IV-VI), severe face involvement (high SA-VES of the face) and depression (high PHQ-9 score) were positively associated with a higher score of stigmatization, although this association was weak (r=0.24, p value <0.001 and r=0.30, p value <0.001 respectively). Cut-off values of the PUSH-D that best discriminated patients with high and low stigma, as defined by the anchor question, were 13 and 23, (K=0.622, 95% IC [0.53; 0.71]). Our study is the first using a skin specific stigmatization tool to assess the stigma in patients with vitiligo. Creating strata helps to better interpret the PUSH-D in daily practice and may facilitate its use in clinical trials.

Laryngeal photobiomodulation: application sites, interferences from body mass index and skin phototype.

Establish points on the neck, correspondent to the laryngeal topography, where to apply Low Level Light therapy (LLLT), to evaluate the incidence of light through variables such as skin phototype and body mass index (BMI). This is a cross-sectional, analytical, observational study, carried out with 15 vocally healthy women, between 18 and 50 years of age, who were divided into three groups, according to BMI and skin phototype. Six anatomical reference points were established to locate the larynx and its musculature, with visual monitoring by videonasolaryngoscopy, to assess light reach (present/absent) and degree of illumination (from very weak to very strong) in the larynx during the LASER application at doses of 3J, 6J and 9J. A flexible endoscope was used for visual monitoring during the LASER application, and subsequent image analysis. The light reached the larynx at doses of 3J, 6J and 9J, in the anterior commissure of the vocal folds, membranous (thyroarytenoid muscle) and cartilaginous portions of the vocal fold and the cricothyroid muscle. The degree of LASER light illumination decreased in overweight and obese participants and increased in moderate brown and dark brown skin phototypes. Data suggest that the LLLT penetrates differently according to skin phototype and BMI, being more evident in individuals with Fitzpatrick IV and V phototypes and less evident with higher BMI levels. The evidence that the LASER light reaches the larynx in specific anatomical points provides direction for the standardization of its use in voice practice.

Sun exposure behaviours as a compromise to paradoxical injunctions: Insight from a worldwide survey.

Behavioural interventions can improve attitudes towards sun protection but the impact remains inconsistent worldwide. To assess awareness of and attitudes towards the multiple facets of sun exposure and suggest ways to improve prevention from overexposure to the sun in all geographical zones and multiple skin types. Online survey was conducted from 28 September to 18 October 2021. Study population was selected from the Ipsos online Panel (3,540,000 panellists), aged ≥18 years, from 17 countries around the five continents. Demographics, sun-exposure habits and practices, understanding of risks and information on phototypes were documented and analysed using descriptive statistics. Eighty-eight per cent of participants knew that sunlight can cause skin health problems (90% phototypes I-II, 82% phototypes V-VI, >90% in American and European countries, 72% in Asia and 85% in Africa). Eighty-five per cent used some form of protection against sunlight, predominantly: Seeking shade (77%), avoiding the midday sun (66%), facial application of sunscreen (60%) and wearing protective clothing (44%). The perception of sunlight itself is positive ('it gives energy' for 82%; 'tanned skin looks attractive' for 72%), although less in Asian countries and among individuals with dark skin phototypes. Eighty-three per cent reported having experienced sunburn, mainly in Australia, Canada, USA, Germany, France and Russia, and among individuals with dark skin phototypes. Only 12% systematically/often used all types of protection during exposure to the sun and 23% believed it is safe to go out in the sun with no protection when their skin is already tanned. From 13% (skin phototype I) to 26% (phototype VI) reported not using any form of protection against the sun. Knowledge and habits were significantly superior among people who are accustomed to seeing a dermatologist for a complete skin exam. Dermatologists could play a crucial role in relaying novel prevention messages, more finely tailored to specific risks, populations and areas of the world.

Acne characteristics in Latin American patients and the potential role of trifarotene.

Individualization of treatment based on acne type and severity, location, disease burden, and patient preference is required to maximize efficacy, safety, and adherence to therapy. Latin American populations have unique attributes that must be considered as part of this process to improve clinical success and achieve patient goals. Acne is more common among patients with darker skin phototypes, in whom it is often associated with postinflammatory hyperpigmentation and scarring-the most important acne sequelae-potentially due to more frequent and more severe underlying inflammatory processes in this population. These data argue for an early and proactive approach to managing acne in these patients with agents that target the inflammatory processes that underlie acne and its sequelae. As a class, retinoids offer a spectrum of activity that may be useful in addressing the unique needs of Latin American populations. Trifarotene, a novel, selective retinoid, has been evaluated in relevant patient populations.

Energy-based devices in the treatment of acne scars in skin of color.

Acne scarring is disfiguring and psychologically taxing on patients. Many energy-based modalities have emerged and been studied for the treatment of acne scarring; however, there is a paucity of these studies in skin phototypes IV-VI. To review the medical literature and discuss the most significant studies regarding safety and efficacy of energy-based devices (ablative lasers, non-ablative lasers, and radiofrequency microneedling) in the treatment of ethnic skin (skin phototypes IV-VI). A literature search was conducted using the PubMed database and bibliographies of relevant articles. Ablative and non-ablative lasers have proven to be effective for treatment of acne scars in ethnic skin. The risk of developing adverse effects such as post-inflammatory hyperpigmentation is contingent upon several factors including skin phototype, laser device, fluence, and moreso density settings. Non-ablative fractional lasers have been considered first line for the treatment of acne scars in skin of color due to their better safety profile; however, they are less efficacious and require more treatments compared to ablative lasers. Studies regarding efficacy and safety of radiofrequency microneedling for treatment of acne scarring in skin of color are limited, but are promising. Ablative lasers, non-ablative lasers, and radiofrequency microneedling are all useful treatments for acne scarring in ethnic skin when appropriate settings are used. Further head-to-head studies are needed to evaluate their efficacy and safety in darker skin phototypes V-VI.

Melanotic lupus erythematosus: A review of a newly described clinical form of chronic cutaneous lupus erythematosus.

Melanotic lupus erythematosus (LE) is a rare and newly described form of chronic cutaneous LE. In this review, we have synthesized existing data on the epidemiologic, clinical, histologic, and immunologic features of melanotic LE. We performed a systematic review using PubMed to identify eligible publications. Eight contributions fulfilled the eligibility criteria and were included in the qualitative synthesis. Twenty-eight patients with a mean age of 57.7 years were included. All patients had medium to dark skin phototypes. The lesions presented either as solitary and localized, poorly limited, round, or oval patches (50%) or as a more diffuse or generalized, sometimes reticulated, hyperpigmentation (50%). Patients diagnosed with systemic LE accounted for 14% of included cases. Antinuclear antibodies were positive in 10.7% of cases. Hydroxychloroquine and topical steroids were the most commonly used treatments. Complete resolution of the lesions was noted in 27.27% of cases. No patient experienced atrophy, destruction, or deformity of the skin. Melanotic LE appears to affect mainly patients with dark phototypes. It is characterized by late age at the onset of disease and an overall good prognosis.

Dermoscopy of the Diverse Spectrum of Cutaneous Tuberculosis in the Skin of Color.

Cutaneous tuberculosis is an uncommon form of tuberculosis, accounting for 1%-2% of all forms of extra-pulmonary tuberculosis. Knowledge of the dermoscopic characteristics of different clinical types of cutaneous tuberculosis can help timely diagnosis resulting in better outcomes. To characterize the Dermoscopy findings in different clinical types of cutaneous tuberculosis in dark skin phototypes. All clinically suspected and biopsy confirmed cases of cutaneous tuberculosis seen from July 2019 through December 2021 were retrospectively recruited. Information including age, gender, disease duration, site and morphology of lesions, and presence of concomitant tuberculosis elsewhere was noted. Two investigators retrospectively reviewed the dermoscopic characteristics of these cases. Twenty-two patients comprised of 12 women and 10 men met the inclusion criteria. Lupus vulgaris was the commonest presentation of cutaneous tuberculosis seen in 13 patients. Five had scrofuloderma, 2 had tuberculosis verrucosa cutis and 1 patient each had lichen scrofulosorum and papulo-necrotic tuberculid. Yellow-orange structureless areas (100%), linear/dot vessels (100%), white scales (92.3%), and white structureless areas (84.6%) were the predominant dermoscopy findings in lupus vulgaris. In scrofuloderma, linear vessels and white structureless areas were visible in all cases. Dirty white scales with a papillated surface were characteristically seen in tuberculosis verrucosa cutis, with 1 of the 2 patients each showing vessels and yellow-orange structureless areas. White globules with surrounding erythema were seen in lichen scrofulosorum and yellow-orange structureless areas with keratin plugs in papulo-necrotic tuberculid. A thorough understanding of the characteristic dermoscopy of cutaneous tuberculosis can help suspect the diagnosis early resulting in better management opportunity.

Comparing Traditional and in Motion Nd:YAG Laser in Hair Removal: A Prospective Study.

Background and Objectives: Hair removal is a common cosmetic problem interesting more and more patients nowadays. Various laser treatments are currently available. Alexandrite and Nd:YAG laser are the most effective procedures in lighter and darker skin phototypes, respectively. Materials and Methods: A total of 40 patients seeking hair removal in one or more body areas with skin phototypes 2–6 was recruited to perform this study. Patients were divided into two groups. One group was treated with the standard Nd:YAG hair removal procedure, while the other group was treated with a new “in motion” Nd:YAG technology. Results and hair removal rates were evaluated six months after the last treatment. Results: Out of 40 patients treated, all patients experienced hair reduction. No statistically significant difference in hair removal was noted between the two groups; however, a statistically significant reduction in pain during the procedure was observed in the group treated with the “in motion” technique. Conclusions: While traditional and “in motion” Nd:YAG techniques have similar result outcomes in hair removal, the “in motion” technology seems to guarantee a better safety profile compared with the traditional technique. A more extensive clinical study will be necessary to confirm our study’s results.

32329 Assessing the utility of Fontana-Masson and MART-1 stains in evaluating skin pigmentary changes induced by ultraviolet radiation and visible light

One of the observed effects of ultraviolet radiation (UVR) and visible light (VL) on melanocompetent skin is increased pigmentation, also known as skin darkening or tanning. Many methods are used to measure skin pigment, including the Fontana-Masson stain (FMS) and MART-1 immunostain, which histologically highlight melanin and melanocyte density, respectively. While these approaches may be adequate in assessing baseline skin pigment among individuals of different races and phototypes, detecting the skin darkening induced by UVR and VL within the same individual is a challenge, especially in darker skin phototypes. We conducted a literature search and analyzed 16 articles comparing skin pigmentation changes induced by VL and UVR to their corresponding FMS and MART-1 results. Notably, significant skin darkening could be detected by diffuse reflectance spectroscopy after irradiation in skin phototypes III-VI, but FMS and MART-1 were unable to significantly differentiate these changes and reliably enumerate them within the same studies. Outcome measurements of FMS and MART-1 may be affected by several factors across studies, such as varying spectrums of radiation, radiation doses, skin phototypes, and subjectivity of the rater. Our results indicate that objective instrumental assessments, such as spectroscopy, are likely superior to FMS and MART-1 for measuring skin pigmentary changes induced by UVR and VL. Further research is recommended to investigate the value in performing FMS and MART-1 stains in future studies evaluating skin tanning from UVR and VL.

Pigmented squamous cell carcinoma in situ with amyloid deposition mimicking melanoma

Pigmented squamous cell carcinoma in situ with amyloid deposition mimicking melanoma

Characteristics of Riehl melanosis in an ethnic Asian population: A comparative study according to age, sex, and hair dye use

AbstractBackgroundRiehl melanosis, characterized by diffuse brown to grey hyperpigmentation of the face and neck, affects middle‐aged women with dark skin phototypes. Riehl melanosis prevalence has increased in Korea, and a relationship with henna hair dye has been suspected. In this study, we aimed to evaluate clinical features and patch test results of Riehl melanosis patients and analyse them according to age, sex, and hair dye use.MethodsWe identified patients showing clinical and histopathological manifestations consistent with Riehl melanosis between January 2009 and December 2019 in our medical centre.ResultsOf 154 patients, 76.5% had positive patch‐test results, and the most common sensitizing agents were nickel, cobalt, and benzyl salicylate. Patients ≥50 years old were more likely to have spotty hyperpigmentation and less likely to have diffuse patterns, while lesions in the younger‐aged group were more commonly accompanied by erythema. Preceding erythema was found more often in female patients. Hair dye usage was more likely to be associated with aggravation of symptoms in females. Patients who developed Riehl melanosis after hair‐dye use more frequently had lesions on the forehead and were diagnosed an average of 14.1 months earlier as compared with other patients. Short disease duration, aggravation by hair dye (except henna), laser therapy, and longer follow‐up periods were related to good treatment responses.ConclusionsDetailed history taking regarding disease duration and aggravating factors as well as the length of the period of laser therapy can be important for the management of Riehl melanosis patients.

Dermatological conditions in skin of colour

The UK has rapidly diversifying demographics in common with most advanced, globalised economies. There is therefore an emerging, integral need for clinicians to recognise and manage skin and hair conditions across all ethnicities. When we discuss skin of colour, we refer to a spectrum of diverse geographic ancestral origins, including, but not limited to, those of Asian, African, Middle Eastern or Hispanic/Latino descent, as well as people of mixed heritage. Patients with darker skin phototypes (Fitzpatrick IV-VI) may experience additional complications and present differently to lighter skin counterparts. Knowledge of these nuances will undoubtably lead to better care and outcomes for patients. In this article, we explore skin and hair conditions that are common and important in patients with skin of colour.

Numerical Modeling of The Dysplastic Vessel Heating in PWS by Yellow 578 nm Copper Vapor Laser Radiation for Different Skin Phototypes.

Introduction: Many clinical studies and protocols have been written about laser treatment for fair skin phototypes. However, for dark-skinned phototypes, information is limited, and the risk of burns is higher, especially if the same settings are recommended for fair skin. Competitive epidermal melanin absorption decreases the light energy reaching dysplastic vessels in a port-wine stain (PWS), preventing the vessel from achieving the temperature of the desired clinical result. Therefore, the choice of safe laser settings for different skin phototypes can be realized using numerical modeling of PWS vessel heating. This study aimed to demonstrate the algorithm for choosing both effective and safe photodestruction of dilated dermal vessels in PWS with the copper vapor laser (CVL) at 578 nm for different skin phototypes. Methods: We used the multilayered skin model with different melanin content for detecting the safe laser parameters for PWS treatment. The calculation of the selective heating of the vascular component with CVL radiation at yellow 578-nm wavelengths for different skin phototypes was performed via Matlab mathematical programming system and its application Femlab for solving partial differential equations using the Finite element method. Results: We determined the location, depth, and size of blood vessels that could be selectively heated to coagulation temperature for different skin prototypes. CVL fluence values need to be reduced almost two times for skin phototype IV than for skin phototype II to provide safe CVL treatment. The maximum depth of the location of the vessels, which can be selectively heated to coagulation temperature, also decreased for dark skin phototypes. Histological and histochemical findings validated the results of our calculations. Conclusion: To our knowledge, the use of numerical simulation to optimize has not yet been considered. According to our calculations, CVL could selectively heat the dilated vessel, which occurred in purple and proliferative-type PWS for dark skin at the reduced fluence range and depth.